[1]怀晴雨应娇茜 姜达伟张奥 胡云梦胡凌娟.临床用血审核制度关键因素分析与对策建议[J].中国卫生质量管理,2023,30(02):008-11.[doi:10.13912/j.cnki.chqm.2023.30.2.03 ]
　HUAI Qingyu,YING Jiaoqian,JIANG Dawei.Analysis of the Key Factors of Review System for Clinical Blood Use and Countermeasures[J].Chinese Health Quality Management,2023,30(02):008-11.[doi:10.13912/j.cnki.chqm.2023.30.2.03 ]
点击复制

临床用血审核制度关键因素分析与对策建议
分享到：

《中国卫生质量管理》[ISSN:1006-7515/CN:CN 61-1283/R]

卷:
第30卷
期数:
2023年02期
页码:
008-11
栏目:
特别关注
出版日期:
2023-02-15

文章信息/Info

Title:
Analysis of the Key Factors of Review System for Clinical Blood Use and Countermeasures
作者:
怀晴雨应娇茜 姜达伟张奥 胡云梦胡凌娟
北京中医药大学管理学院
Author(s):
HUAI Qingyu; YING Jiaoqian; JIANG Dawei
School of Management, Beijing University of Chinese Medicine
关键词:
医疗质量安全核心制度; 临床用血审核制度; 医疗质量; 输血安全
Keywords:
Core System of Medical Quality and Safety;  Blood Review System for Clinical Use;  Medical Quality;  Blood Transfusion Safety
分类号:
R197.323
DOI:
10.13912/j.cnki.chqm.2023.30.2.03
文献标志码:
B
摘要:
临床用血审核制度是确保患者用血安全的重要保障。通过案例回顾，对血液交接与信息核对不到位、输血申请单填写不规范、交叉配血未复核等临床用血问题进行了分析，并从人员、环节、技术三方面阐述了临床用血审核制度的关键因素。提出医院需加强培训，强化信息化监管，加强多学科协作等，以促进临床用血审核制度的落实，提高输血效率，确保输血安全。
Abstract:
The review system for clinical blood use is an important guarantee for the safety of blood use. Through case review, the problems of clinical blood use such as incomplete information check before blood handover, non-standard filling in blood transfusion application form, and no review of cross-matching blood were expounded. The key factors of the review system of clinical blood use were also discussed from the aspects of personnel, links and technology. It is suggested that hospitals should strengthen training, strengthen information supervision, strengthen multidisciplinary cooperation, etc., in order to promote the implementation of review system for clinical blood use, improve blood transfusion efficiency and ensure blood transfusion safety.

参考文献/References:

［1］国家卫生健康委员会．医疗质量安全核心制度要点［Ｚ］．２０１８． ［2］王文婷，穆士杰.应用互动式临床用血监管模式提升医院用血质量［J］.中国输血杂志，2018，31（9）：1054-1056. ［3］姚 洁，任 伟，王 欣，等.基于HIMSS EMRA 7的临床用血信息化管理［J］.中国卫生质量管理，2019，26（1）：22-24. ［4］卫生部办公厅.关于印发《临床输血技术规范》的通知：卫医发〔2000〕184号［EB/OL］.（2000-06-02）［2022-08-15］.https://www.u9seo.com/post/25530.html. ［5］徐茂云,刘丙龙.医院临床用血审核管理现状［J］.解放军医院管理杂志,2019,26(4):361-362，370. ［6］李桐杨,祝 伟,邓 雯,等.违反医疗核心制度行为在医疗事故罪认定中的作用［J］.中国卫生质量管理,2019,26(6):107-110. ［7］李跃林,王 东,唐承模.基于血液闭环管理的临床输血及合理用血监管系统［J］.中国信息化,2021(12):23-25. ［8］郭 凡,程念开,王 敏，等.移动输血闭环信息系统在临床输血全流程管理中的应用［J］.中国输血杂志,2022,35(9):995-998. ［9］刘 璇，陈麟凤，庄健美，等．除输血不良反应外临床用血相关不良事件分析［J］．中华医学杂志，2019，99(6)：438—441． ［10］王忠庆,邵 尉,程大也,等.临床输血闭环管理信息系统的设计与应用［J］.中国数字医学,2015,10(5):44-46.

相似文献/References:

[1]应娇茜王晨曦.值班和交接班制度问题分析与改进建议[J].中国卫生质量管理,2021,28(02):009.[doi:10.13912/j.cnki.chqm.2021.28.2.04 ]
　YING Jiaoqian,WANG Chenxi.Problems Analysis and Suggestions for Improvement of Duty and Shift System[J].Chinese Health Quality Management,2021,28(02):009.[doi:10.13912/j.cnki.chqm.2021.28.2.04 ]
[2]梁小慧侯娜莉付长红应娇茜孙乐明高鹏怀晴雨吴修荣俞淑静.基于医疗损害责任纠纷案件的查对制度问题分析与建议[J].中国卫生质量管理,2023,30(02):001.[doi:10.13912/j.cnki.chqm.2023.30.2.01 ]
　LIANG Xiaohui,HOU Nali,FU Changhong.Analysis and Countermeasures on the Inspection System Based on Medical Damage Liability Dispute Cases[J].Chinese Health Quality Management,2023,30(02):001.[doi:10.13912/j.cnki.chqm.2023.30.2.01 ]
[3]曾强怀晴雨姜义山姜达伟陈兰高鹏应娇茜.基于司法判决角度的危急值报告制度管理策略[J].中国卫生质量管理,2023,30(02):004.[doi:10.13912/j.cnki.chqm.2023.30.2.02 ]
　ZENG Qiang,HUAI Qingyu,JIANG Yishan.Management Strategy of Critical Value Reporting System from the Perspective of Judicial Decision[J].Chinese Health Quality Management,2023,30(02):004.[doi:10.13912/j.cnki.chqm.2023.30.2.02 ]
[4]俞德梁 刘小南.日间手术模式下值班和交接班制度的分析与思考[J].中国卫生质量管理,2024,31(08):034.[doi:10.13912/j.cnki.chqm.2024.31.8.07]
　YU Deliang,LIU Xiaonan.Analysis and Exploration of Duty and Shift Change System under the Ambulatory Surgery Mode[J].Chinese Health Quality Management,2024,31(02):034.[doi:10.13912/j.cnki.chqm.2024.31.8.07]

更新日期/Last Update: 2023-02-15